|
| 回到 StockQ 正常版首頁 |
|
| 技術線圖 |
| 5日平均 | 10日平均 | 20日平均 |
| 6625.13 | 6666.72 | 6705.10 |
| 60日平均 | 120日平均 | 260日平均 |
| 6524.85 | 6533.68 | 6065.75 |
| Date | Price | Change% |
| 2025/04/01 | 6568.4663 | -0.03% |
| 2025/03/31 | 6570.5 | -1.16% |
| 2025/03/28 | 6647.843 | -0.58% |
| 2025/03/27 | 6686.622 | 0.52% |
| 2025/03/26 | 6652.197 | 0.23% |
| 2025/03/25 | 6637.136 | -0.36% |
| 2025/03/24 | 6661.321 | 0.34% |
| 2025/03/21 | 6638.959 | -1.95% |
| 2025/03/20 | 6771.2705 | -0.90% |
| 2025/03/19 | 6832.902 | -0.21% |
| 2025/03/18 | 6847.324 | 0.43% |
| 2025/03/17 | 6818.046 | 0.04% |
| 2025/03/14 | 6815.114 | 2.12% |
| 2025/03/13 | 6673.849 | -0.67% |
| 2025/03/12 | 6718.786 | 0.01% |
| 2025/03/11 | 6718.218 | -0.00% |
| 2025/03/10 | 6718.457 | -0.22% |
| 2025/03/07 | 6733.2285 | -0.35% |
| 2025/03/06 | 6757.015 | 1.84% |
| 2025/03/05 | 6634.768 | 0.28% |
相關基金績效 (可點按欄位名稱排序)
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 中小板指指數 | 10.10% | 5.58% | 23.44% | 3.66% |
| 聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
| 聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
| 聯博中國A股基金-A2類型/台幣 | 2.68% | -2.88% | 11.93% | 2.68% |
| 聯博中國A股基金-A2類型/美元 | 1.37% | -7.43% | 7.85% | 1.37% |
| 聯博中國A股基金-A2類型/人民幣 | 0.34% | -3.82% | 7.84% | 0.34% |
| 富達中國聚焦基金/美元 | 10.12% | 1.07% | 18.48% | 10.12% |
| 法巴中國股票基金-C股/美元 | 14.73% | 7.67% | 32.36% | 14.73% |
| 安聯中國策略基金/台幣 | 2.84% | -0.89% | 14.81% | 2.84% |
| 安聯中國股票基金-A股/配息/美元 | 12.50% | 1.29% | 27.41% | 12.50% |
| 霸菱香港中國基金-A類/配息/歐元 | 9.36% | 4.79% | 26.76% | 9.36% |
| 霸菱香港中國基金-A類/配息/美元 | 13.67% | 1.33% | 27.14% | 13.67% |
| 霸菱香港中國基金-A類/配息/英鎊 | 10.16% | 4.99% | 23.93% | 10.16% |
| 貝萊德中國基金A2/美元 | 12.67% | 4.34% | 30.44% | 12.67% |
| 貝萊德中國基金A2-歐元避險 | 11.66% | 2.83% | 27.57% | 11.66% |
| 貝萊德中國基金A2-澳幣避險 | 11.98% | 3.46% | 27.81% | 11.98% |
| 群益華夏盛世基金/台幣 | -0.70% | -0.32% | 5.33% | -0.70% |
| 群益華夏盛世基金/美元 | -1.90% | -4.94% | 1.56% | -1.90% |
| 群益華夏盛世基金/人民幣 | -2.71% | -1.36% | 1.61% | -2.71% |
| 群益中國新機會基金/台幣 | -1.67% | -3.13% | 3.02% | -1.67% |
| 群益中國新機會基金/美元 | -2.82% | -7.48% | -0.61% | -2.82% |
| 群益中國新機會基金/人民幣 | -3.62% | -3.99% | -0.56% | -3.62% |
| DWS投資中國股票基金E2/美元 | 13.16% | 2.89% | 32.39% | 13.16% |
| DWS投資中國股票基金A2/美元 | 12.91% | 2.44% | 31.24% | 12.91% |
| DWS投資中國股票基金FC/歐元 | 8.96% | 6.37% | 32.42% | 8.96% |
| DWS投資中國股票基金LC/歐元 | 8.74% | 5.94% | 31.37% | 8.74% |
| 瀚亞中國基金/台幣 | 3.05% | -4.83% | 7.54% | 3.05% |
| 瀚亞中國股票基金/美元 | 14.12% | 3.96% | 30.35% | 14.12% |
| 愛德蒙得洛希爾中國基金(A)/歐元 | 8.54% | 13.26% | 38.39% | 8.84% |
| 愛德蒙得洛希爾中國基金(A)/美元 | 12.71% | 9.66% | 38.69% | 13.75% |
| 歐義銳榮中國股票基金-R/歐元 | 9.94% | 13.81% | 36.19% | 10.02% |
| 歐義銳榮中國股票基金-R2/美元 | 14.17% | 10.19% | 36.49% | 14.99% |
| 首域盈信中國核心基金/美元 | 8.92% | -3.23% | 18.32% | 8.92% |
| 富蘭克林華美中國消費基金/台幣 | 0.71% | -3.22% | 10.22% | 0.71% |
| 富蘭克林華美中國傘型基金之中國A股基金/台幣 | 0.11% | -3.64% | 9.61% | 0.11% |
| 富蘭克林華美中國傘型基金之中國A股基金/人民幣 | -2.11% | -4.82% | 5.76% | -2.11% |
| 富蘭克林華美中國傘型基金之中國A股基金/美元 | -1.15% | -8.15% | 5.68% | -1.15% |
| 復華華人世紀基金/台幣 | -4.84% | 2.61% | 9.78% | -4.84% |
| 復華大中華中小策略基金/台幣 | -13.68% | -11.92% | -5.02% | -13.68% |
| 匯豐中國動力基金-台幣 | 2.67% | 1.10% | 16.56% | 2.67% |
| 匯豐中國股票基金AD/美元 | 13.12% | 6.41% | 27.08% | 13.12% |
| 景順中國基金-A股/美元 | 12.00% | 3.44% | 28.27% | 12.00% |
| 景順中國基金-A股/歐元對沖 | 11.68% | 2.30% | 25.71% | 11.68% |
| 景順中國基金-A股/澳幣對沖 | 12.24% | 3.09% | 26.35% | 12.24% |
| 摩根中國基金-A股/分派/美元 | 11.15% | 0.15% | 26.96% | 11.15% |
| 木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
| 木星中國基金–ACC/英鎊 | 10.96% | 18.87% | 39.74% | 10.96% |
| 野村中國機會基金/台幣 | 7.53% | 0.00% | 13.81% | 7.53% |
| 鋒裕匯理-中國股票基金-A2/美元 | 13.11% | 3.36% | 25.85% | 13.11% |
| 鋒裕匯理-中國股票基金-B2/美元 | 12.96% | 3.00% | 24.92% | 12.96% |
| 鋒裕匯理-中國股票基金-A2/歐元 | 8.50% | 6.80% | 25.78% | 8.50% |
| 荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
| 荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
| 新光中國成長基金/台幣 | 5.40% | 2.91% | 12.97% | 5.40% |
| 瑞銀(盧森堡)中國精選股票基金/美元 | 12.99% | 1.10% | 23.83% | 12.99% |
| 瑞銀(盧森堡)中國精選股票基金-月配息/美元 | 12.44% | 0.08% | 21.36% | 12.44% |
| 元大新中國基金/台幣 | 1.86% | -3.86% | 8.31% | 1.86% |
| ( 中國基金 ) | 5.83% | 0.72% | 16.63% | 5.25% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|